GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Bioengineering Co Ltd (SZSE:000078) » Definitions » EV-to-Revenue

Shenzhen Neptunus Bioengineering Co (SZSE:000078) EV-to-Revenue : 0.39 (As of Jun. 23, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shenzhen Neptunus Bioengineering Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shenzhen Neptunus Bioengineering Co's enterprise value is ¥13,348 Mil. Shenzhen Neptunus Bioengineering Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥34,549 Mil. Therefore, Shenzhen Neptunus Bioengineering Co's EV-to-Revenue for today is 0.39.

The historical rank and industry rank for Shenzhen Neptunus Bioengineering Co's EV-to-Revenue or its related term are showing as below:

SZSE:000078' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.38   Med: 0.51   Max: 2.65
Current: 0.39

During the past 13 years, the highest EV-to-Revenue of Shenzhen Neptunus Bioengineering Co was 2.65. The lowest was 0.38. And the median was 0.51.

SZSE:000078's EV-to-Revenue is ranked better than
93.91% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs SZSE:000078: 0.39

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), Shenzhen Neptunus Bioengineering Co's stock price is ¥2.14. Shenzhen Neptunus Bioengineering Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥13.29. Therefore, Shenzhen Neptunus Bioengineering Co's PS Ratio for today is 0.16.


Shenzhen Neptunus Bioengineering Co EV-to-Revenue Historical Data

The historical data trend for Shenzhen Neptunus Bioengineering Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Bioengineering Co EV-to-Revenue Chart

Shenzhen Neptunus Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.54 0.48 0.51 0.48

Shenzhen Neptunus Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.49 0.51 0.48 0.44

Competitive Comparison of Shenzhen Neptunus Bioengineering Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Bioengineering Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Neptunus Bioengineering Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Bioengineering Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Bioengineering Co's EV-to-Revenue falls into.



Shenzhen Neptunus Bioengineering Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shenzhen Neptunus Bioengineering Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13347.985/34548.858
=0.39

Shenzhen Neptunus Bioengineering Co's current Enterprise Value is ¥13,348 Mil.
Shenzhen Neptunus Bioengineering Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥34,549 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Neptunus Bioengineering Co  (SZSE:000078) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shenzhen Neptunus Bioengineering Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.14/13.286
=0.16

Shenzhen Neptunus Bioengineering Co's share price for today is ¥2.14.
Shenzhen Neptunus Bioengineering Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥13.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Neptunus Bioengineering Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Bioengineering Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Neptunus Bioengineering Co (SZSE:000078) Business Description

Traded in Other Exchanges
N/A
Address
Science and Technology Middle Road, 24th Floor, Haiwang Yinhe Technology Building, No. 1, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Neptunus Bioengineering Co Ltd is primarily engaged in the research and development, manufacture and distribution of pharmaceutical products in China.
Executives
Shen Da Kai Directors, executives
Ren Ke Lei Independent director
Zhang Si Min Director
Zhang Yi Fei Directors, executives
Liu Zhan Jun Directors, executives
Zhang Quan Li Directors, Directors, and Executives
Song Ting Jiu Executives
Yu Lin Directors, executives
Feng Han Lin Supervisors
Zhang Wen Zhou Director
Nie Zhi Hua Supervisors
Huang Lei Executives
Zhang Li Jun Executives

Shenzhen Neptunus Bioengineering Co (SZSE:000078) Headlines

No Headlines